← Leaderboards
Mitchell M Scheiman
Salus University
$6,686,082
Attributed
$6,686,082
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $854K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,686,082 · 4
By mechanism
U10$6,578,282 · 3
R21$107,800 · 1
Top collaborators
No co-investigators on record.
Most similar at Salus University
Same institution · by research overlap
- Elise B Ciner$2,125,289
- Michael Gallaway$925,395
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsProceduresChildManualsParentsMyopiaParticipantFollow-UpBaseFutureBlindnessVision DisordersBinocular VisionRandomizedClinical ResearchMasksHuman SubjectHuman Therapy EvaluationEvaluationLongitudinal Human StudyOutcome MeasureApplications GrantsAgedChairperson
Grant awards (25)
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$1
U10 · FY2018 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$346,170
U10 · FY2017 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$608,842
U10 · FY2016 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$64,377
U10 · FY2016 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$35,453
U10 · FY2016 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$710,361
U10 · FY2015 · EY · contact PI
Convergence Insufficiency Treatment Trial - Attention and Reading Trial$483,711
U10 · FY2014 · EY · contact PI
Collaborative Observational Study of Myopia in Comet Children$173,847
U10 · FY2013 · EY · contact PI
Collaborative Observational Study of Myopia in Comet Children$261,047
U10 · FY2012 · EY · contact PI
Collaborative Observational Study of Myopia in Comet Children$256,984
U10 · FY2011 · EY · contact PI
Collaborative Observational Study of Myopia in Comet Children$251,030
U10 · FY2010 · EY · contact PI
Collaborative Observational Study of Myopia in Comet Children$249,360
U10 · FY2009 · EY · contact PI
Collaborative Observational Study of Myopia in Comet Children$66,402
U10 · FY2009 · EY · contact PI
COLLABORATIVE OBSERVATIONAL STUDY OF MYOPIA IN COMET CHILDREN$179,897
U10 · FY2007 · EY · contact PI
Convergence Insuffiency Treatment Trial$443,503
U10 · FY2006 · EY · contact PI
COLLABORATIVE OBSERVATIONAL STUDY OF MYOPIA IN COMET CHILDREN$185,285
U10 · FY2006 · EY · contact PI
Convergence Insuffiency Treatment Trial$674,113
U10 · FY2005 · EY
COLLABORATIVE OBSERVATIONAL STUDY OF MYOPIA IN COMET CHILDREN$179,877
U10 · FY2005 · EY
Convergence Insuffiency Treatment Trial$642,031
U10 · FY2004 · EY
COLLABORATIVE OBSERVATIONAL STUDY OF MYOPIA IN COMET CHILDREN$178,118
U10 · FY2004 · EY
COLLABORATIVE OBSERVATIONAL STUDY OF MYOPIA IN COMET CHILDREN$152,659
U10 · FY2003 · EY
CORRECTION OF MYOPIA EVALUATION TRIAL (COMET)$145,850
U10 · FY2002 · EY
CORRECTION OF MYOPIA EVALUATION TRIAL (COMET)$146,368
U10 · FY2001 · EY
CORRECTION OF MYOPIA EVALUATION TRIAL (COMET)$142,996
U10 · FY2000 · EY
CONVERGENCE INSUFFICIENCY TREATMENT TRIAL$107,800
R21 · FY2000 · EY